FDA offers PharmAust clear guidance for orphan drug designation approval
FDA seeks clinical trial data from PharmAust to support its Orphan Drug Designation in the treatment of MND/ALS PharmAust to unveil Phase 1 MEND Study [more…]
Enivo pilot clinical study shows promise for reducing mastectomy complications
AROA’s Enivo system shows promise in management of dead space following mastectomy All enrolled patients so far have successfully undergone a unilateral mastectomy and follow-up, [more…]
‘Four from four’: DeSoto strikes gold in all diamond holes at its Fenton project
Three high priority targets have been identified from surveys at Fenton All four drill holes intersected gold mineralisation Follow-up AEM surveys are planned to create [more…]
Ground Breakers: Goldman’s copper bullishness continues to reign supreme … but IGO’s Greenbushes news could put a dampener on things
Goldman maintains bullish copper outlook and warns supply crunch could come quicker than expected IGO downgrades lithium output from Greenbushes Gold Road, Bellevue, Fenix and [more…]
Top 10 at 10: Gold acquisitions, messy legal stuff, and this why we have the African Discount
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Straker translates stabilising market conditions to profits in Q3
Straker reports record gross margins and ongoing profitability in Q3 Delivers positive Operating Cash Flow and Free Cash Flow Company flags new product launches in [more…]
Legacy Minerals set for $6m boost after farming out its Glenlogan copper-gold project to S2 Resources
S2 will spend $6m over five years for a 70% interest in Glenlogan Glenlogan is hosted in the mineral-rich Lachlan Fold belt, which is known [more…]
Market Highlights: ASX to edge closer to record high ahead of Fed meeting, Big Tech earnings this week
ASX to extend winning streak on Monday as the S&P500 finally retreats Fed Reserve to meet and announce rate decision later this week The rest [more…]
Long Shortz with GCX Metals: An action-packed year ahead at Dante
GCX Metals reels in high-grade results from the Dante project in WA, the first samples collected by the company within the 140,000km2 copper-rich West Musgrave [more…]
What’s in store 2024: CuFe
Stockhead’s Ashtyn Hiron sits down with CuFe (ASX:CUF) executive director Mark Hancock to close the books on 2023 and gain a sneak peek into what’s [more…]
